Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Base Ten allowed Prenval technology patent; Computerized diagnostic engine intended for many disorders.


Inc. (NASDAQ-NMS:BASEA BASEA Boston Area Solar Energy Association ) announced today that the U.S. Patent Office has notified it of the allowance of its patent application covering a form diagnostic methodology used in the PRENVAL(TM) family of products.

The methodology, referred to by the company as a "computerized diagnostic engine," is used to aid in the assessment of medical risk for a specific disorder in a given patient.

The company was recently granted permission by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 to sell its first PRENVAL(TM) product, PRENVAL(TM)I, in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . As previously announced, last year Base Ten signed an agreement with Johnson & Johnson which included licensing of this same technology for a similar diagnostic product in the international market outside the United States.

The FDA's permission to sell this methodology in PRENVAL(TM)I and the granting of an allowance by the Patent Office, are significant because they will give Base Ten a protected way to apply this technology to testing many disorders. Mike Kranzler, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , stated, "Because the diagnostic engine methodology is the same for many disorders, we believe we can look forward to shorter time to market cycles since we will only have to deal with the design of specific test protocols."

Base Ten Systems, Inc. is a diversified technology company concentrating on the development and sale of safety critical products in the fields of medical software, manufacturing execution systems

Manufacturing execution system (MES) describes a set of integrated functions within a packaged software system or it can also describe the accumulated functionality within the production management infrastructure of a manufacturing or production company.
 and weapons control.

CONTACT: Base Ten Systems Inc.

Edward J. Klinsport, 609/586-7010

or

Strategic Growth International Inc.

Richard Cooper Richard Cooper may refer to:
  • Richard Cooper, Jr (c. 1740–c. 1814), British artist
  • Sir Richard Cooper, 2nd Baronet (1874–1946), British Conservative politician
  • Richard Cooper (football player), former American NFL player
, 516/829-7111
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 30, 1995
Words:253
Previous Article:TheraTech receives patent for transdermal patches that deliver testosterone to women; Announces collaboration with Solvay Pharmaceuticals on new type...
Next Article:Zombie Virtual Reality Entertainment Adds Spark to Microsoft's "Judgment Day" Halloween Event Its Windows 95- Compatible Titles, Ice & Fire and...
Topics:



Related Articles
Base Ten Reaches Agreement with Eastman Kodak for Prenval(TM) Software.
Base Ten announces contract with Miles; first U.S. contract for Pharmasyst(TM).
Base Ten Annual Report.
Base Ten's Premarket Approval application to be reviewed by FDA panel on March 31, 1995.
FDA advisory votes 5 to 3 against Base TEN's Prenval(TM) I approval; vote reflects conflict between FDA and panel members, but PMA remains under...
PRENVAL 1 to receive FDA clearance as a medical device.
Base Ten investor has 14% stake in common stock.
FDA allows Base Ten Systems to immediately market Prenval 1; first product of this type to come before the FDA for clearance.
Base Ten announces second quarter results and other charges.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles